18F-NOS

N/A

Report date: 2025/11/27 15:47:56
NME

Base Information

Drug Name18F-NOS
Drug Alias Name[18F]NOS
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules > Heterocyclic drugs +[5] 
Mechanisms of ActionRadionuclide imaging enhancersNitric oxide synthase inhibitors
TargetsNitric oxide synthase
Therapy Area/IndicationsSmokingOpioid-Related DisordersAlcoholism +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsSmokingOpioid-Related DisordersAlcoholism +[5] 
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A